Welcome to LookChem.com Sign In|Join Free
  • or
2-Methoxy-3-Nitro-5-Picoline is a heterocyclic aromatic compound with the molecular formula C7H7NO3. It features a pyridine ring, a nitro group, and a methoxy group, and is widely recognized for its selective and efficient reactions in chemical synthesis processes. This versatile chemical intermediate is valued for its role in the production of agrochemicals, pharmaceuticals, and other organic compounds, as well as for its potential biological activities, which make it a significant target in medicinal chemistry research.

33252-62-9

Post Buying Request

33252-62-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

33252-62-9 Usage

Uses

Used in Pharmaceutical Industry:
2-Methoxy-3-Nitro-5-Picoline is used as a key intermediate in the synthesis of various pharmaceuticals for its ability to facilitate the creation of complex molecular structures that can exhibit therapeutic effects.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Methoxy-3-Nitro-5-Picoline serves as an essential building block in the development of compounds that can protect crops from pests and diseases, leveraging its reactivity to form agrochemicals with desired properties.
Used in Organic Synthesis:
2-Methoxy-3-Nitro-5-Picoline is utilized as a versatile intermediate in organic synthesis, contributing to the formation of a wide array of organic compounds for various applications, including but not limited to materials science, dyes, and specialty chemicals.
Used in Medicinal Chemistry Research:
2-Methoxy-3-Nitro-5-Picoline is also used as a target in medicinal chemistry research due to its potential biological activities, which can be harnessed to develop new drugs and therapies for various medical conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 33252-62-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,2,5 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 33252-62:
(7*3)+(6*3)+(5*2)+(4*5)+(3*2)+(2*6)+(1*2)=89
89 % 10 = 9
So 33252-62-9 is a valid CAS Registry Number.
InChI:InChI=1/C7H8N2O3/c1-5-3-6(9(10)11)7(12-2)8-4-5/h3-4H,1-2H3

33252-62-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-methoxy-5-methyl-3-nitropyridine

1.2 Other means of identification

Product number -
Other names 2-Methoxy-3-nitro-5-methyl-pyridin

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:33252-62-9 SDS

33252-62-9Relevant academic research and scientific papers

TYK2 INHIBITORS AND USES THEREOF

-

Paragraph 00242; 00342, (2020/09/27)

Described herein are compounds that are useful in treating a TYK2-mediated disorder. In some embodiments, the TYK2-mediated disorder is an autoimmune disorder, an inflammatory disorder, a proliferative disorder, an endocrine disorder, a neurological disorder, or a disorder associated with transplantation.

Identification of 2-Imidazopyridine and 2-Aminopyridone Purinones as Potent Pan-Janus Kinase (JAK) Inhibitors for the Inhaled Treatment of Respiratory Diseases

Bach, Jordi,Eastwood, Paul,González, Jacob,Gómez, Elena,Alonso, Juan Antonio,Fonquerna, Silvia,Lozoya, Estrella,Orellana, Adela,Maldonado, Mónica,Calaf, Elena,Albertí, Joan,Pérez, Juan,Andrés, Ana,Prats, Neus,Carre?o, Cristina,Calama, Elena,De Alba, Jorge,Calbet, Marta,Miralpeix, Montserrat,Ramis, Isabel

supporting information, p. 9045 - 9060 (2019/11/03)

Janus kinases (JAKs) have a key role in regulating the expression and function of relevant inflammatory cytokines involved in asthma and chronic obstructive pulmonary disease. Herein are described the design, synthesis, and pharmacological evaluation of a series of novel purinone JAK inhibitors with profiles suitable for inhaled administration. Replacement of the imidazopyridine hinge binding motif present in the initial compounds of this series with a pyridone ring resulted in the mitigation of cell cytotoxicity. Further systematic structure-activity relationship (SAR) efforts driven by structural biology studies led to the discovery of pyridone 34, a potent pan-JAK inhibitor with good selectivity, long lung retention time, low oral bioavailability, and proven efficacy in the lipopolysaccharide-induced rat model of airway inflammation by the inhaled route.

Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: Synthesis, structure-activity relationships, and biological activities

Lu, Tiangong,Goh, Aik Wye,Yu, Mingfeng,Adams, Julian,Lam, Frankie,Teo, Theodosia,Li, Peng,Noll, Ben,Zhong, Longjin,Diab, Sarah,Chahrour, Osama,Hu, Anran,Abbas, Abdullahi Y.,Liu, Xiangrui,Huang, Shiliang,Sumby, Christopher J.,Milne, Robert,Midgley, Carol,Wang, Shudong

, p. 2275 - 2291 (2014/04/17)

ON01910.Na is a highly effective anticancer agent that induces mitotic arrest and apoptosis. Clinical studies with ON01910 in cancer patients have shown efficacy along with an impressive safety profile. While ON01910 is highly active against cancer cells,

Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases

-

Page/Page column 23, (2012/12/13)

New pyridin-2(1h)-one derivatives having the chemical structure of formula (I) are disclosed; as well as process for their preparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

PYRIDIN-2 (1H) -ONE DERIVATIVES USEFUL AS MEDICAMENTS FOR THE TREATMENT OF MYELOPROLIFERATIVE DISORDERS, TRANSPLANT REJECTION, IMMUNE-MEDIATED AND INFLAMMATORY DISEASES

-

Page/Page column 68, (2012/12/13)

Compoundshaving the chemical structure of formula (I) are disclosed; as well as process for theirpreparation, pharmaceutical compositions comprising them and their use in therapy as inhibitors of Janus Kinases (JAK).

COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS

-

Page/Page column 41, (2012/01/13)

.A compound of formula (I) or a pharmaceutically acceptable salt or solvate or physiologically hydrolysable, solubilising or immobilisable derivative thereof; wherein: any one or two of X·,, X2 and X3 is a N atom and the remaining two or one of X1, X2 and

Metallation in connection with cross-coupling reactions. Coupling of hindered aryls for the synthesis of 4-phenylpyridines as part of Streptonigrin and Lavendamycin analogues

Godard,Rocca,Pomel,Thomas-Dit-Dumont,Rovera,Thaburet,Marsais,Queguiner

, p. 25 - 36 (2007/10/03)

The synthesis of the C-D ring system of Streptonigrin and Lavendamycln alkaloid analogues by cross-coupling under Suzuki's conditions has been studied. Steric hindrance is the main problem. It has been solved either by using strong bases or working in a sealed tube under pressure.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 33252-62-9